Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Urol. 2014 Aug 20;193(2):513–518. doi: 10.1016/j.juro.2014.08.081

Table 4.

Multivariate analysis for presence of teratoma in RPLND specimen (n=432)

Variable OR 95% CI p-value
 Clinical Stage
  I ref
  IIa 0.9 0.3, 2.0 0.7
  IIb/c 0.4 0.2, 0.8 0.02
  III 0.3 0.1,0.6 0.002
 Any Yolk Sac 1.3 0.8, 2.1 0.3
 Any Teratoma in primary tumor 4.3 2.7, 7.0 < 0.001
 Pre-surgery RP node size 1.3 1.1, 1.5 <0.001
 Year of surgery (before 1999 vs. after 1999) 0.7 0.4, 1.1 0.5
 Chemotherapy (EP vs. BEP) 2.0 1.0, 4.0 0.04